- Tytuł:
- Rationale and design of the multicentric, double-blind, double-placebo, randomized trial APrepitant versus HYdroxyzine in association with cytoreductive treatments for patients with myeloproliferative neoplasia suffering from Persistent Aquagenic Pruritus. Trial acronym: APHYPAP
- Autorzy:
- Źródło:
- Trials. 22(1)
Czasopismo naukowe